Minoxidil Market Business Growth Statistics with Pfizer Inc., ATOM PHARMA, LGM Pharma, Perrigo Company plc, AmWiner & Raphe Holdings, Johnson and Johnson Services, Inc., Sigma Aldrich (Merck KGaA)

Minoxidil is an antihypertensive available in topical as well as oral solution used for hair loss treatment. It helps to stimulate hair growth and to slow balding. This drug is U.S. Food & Drug Administration (U.S. FDA) approved for androgenetic alopecia and female pattern hair loss. Moreover, it is also available off label for alopecia areata, beard enhancement, and central centrifugal cicatricial alopecia.

Get PDF Brochure of This Business Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/4375

Major players and research organizations in the market are focused on research and development of novel products, which is expected to boost the market growth. For instance, in November 2018, Tabriz University of Medical Sciences, Iran announced the completion of evaluating the topical herbal solution on the treatment of male pattern hair loss and comparison with minoxidil 5%. This drug is designed to assess the safety, tolerability, and indicators of efficacy of androgenic alopecia in men. The Phase III was initiated in November 2018 and was completed in September 2019.

Global Minoxidil Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 85.92 million infected individuals worldwide as of January 7, 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to lockdowns, several countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of such drugs from one place to another.

Moreover, the COVID-19 pandemic has impacted the supply of raw materials and potent compounds, which are used for manufacturing drugs of androgenetic alopecia and this is expected to hamper the market growth in the near future.

Competitive Analysis

Major players operating in the global minoxidil market include Pfizer Inc., ATOM PHARMA, LGM Pharma, Perrigo Company plc, AmWiner & Raphe Holdings, Johnson and Johnson Services, Inc., Sigma Aldrich (Merck KGaA), Actavis Pharma, Inc., Remedy Repack, Apotex Corporation, TRILOGIC LTD, DS LABORATORIES, INC., Incredible Products, S.A. de C.V., and Taisho Pharmaceutical Co., Ltd among others.

Request For Customization Of This Business Research Report:
https://www.coherentmarketinsights.com/insight/request-customization//4375

Detailed Segmentation:

By Type:
5% Minoxidil
2% Minoxidil

By Route of Administration:
Oral
Topical

By Gender:
Male
Female

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Apply Promo Code “STAYHOME” and Get Up to 30% Discount

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/4375

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.